We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Lateral Flow Multiplexing Designs


Lateral Flow Multiplexing Designs

Who's speaking at this Webinar?

Dr. Klaus Hochleitner
Global Lead Technical Product Specialist, GE Healthcare Life Sciences
Brendan O’Farrell
President, DCN Diagnostics

Lateral flow assays have been in the market for rapid point-of-care diagnostics for more than 30 years. Typically, lateral flow assay only detects one biomarker in one test. Despite having increasing demand for multiplexed systems which can detect multiple biomarkers simultaneously in one test, due to the limitations in the design of traditional membrane-based lateral flow assay, multiplexing is limited to a small number of biomarkers.

Hence, we will be focusing on multiplex lateral flow assay design and discuss the main factors which should be considered when building a multiplex lateral flow assay. Additionally, the complexities involved during multiplex assay design and physical limitations of reagents, membranes, and other components will be covered during the session.

Key Learning Objectives:

Factors affecting the assay design: Time, Temperature, Data/Mobility Requirements
Ways to overcome complexities in assay design
Technical challenges for the multiplex lateral flow assay design
Considerations for the limitations around reagents, membranes and other components in multiplex assay design


Like what you just read? You can find similar content on the communities below.

Diagnostics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free